Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
Examining the role of renal tertiary lymphoid structures in chronic kidney disease
EF 2025-26
Résumé
Chronic kidney disease (CKD) is a leading cause of mortality worldwide and the number of cases is climbing annually. Diagnosis is often delayed, leading many individuals to progress to kidney failure needing lifelong dialysis or a kidney transplant to survive. So, in addition to its significant impact on human health, CKD also represents a major economic burden. Injury to the kidney's filtering units is the main risk factor for developing CKD. This is usually instigated by high blood pressure that injures the delicate vasculature of the kidney's filters, or by immune-mediated damage caused by autoimmune diseases and infections. Regardless of the source of injury, subsequent immune responses mediate a chronically inflamed state that interrupts normal kidney repair, triggering the steady march towards kidney failure. We currently have a poor understanding of the immune responses underlying CKD. Consequently, treatments for CKD remain non-specific and offer suboptimal disease control. Hence, by better characterizing the immune processes involved in CKD progression, we can uncover new therapeutic targets to develop better medicine. In this proposal, we aim to uncover these immune processes by applying cutting-edge spatial transcriptomics technologies on kidneys from CKD donors. Specifically, we will examine special immune cell structures - termed tertiary lymphoid structures (TLS) - that develop in the kidney during CKD. Similar TLS develop in the lungs and gut during infection where they act as hubs to promote immunity, and in tumors serving to enhance anti-tumor immune responses. We predict that kidney TLS also act as centres for augmenting immune responses, but ultimately to the detriment of kidney function, thereby promoting CKD progression. By characterizing the cellular composition of these TLS and evaluating the immune pathways that are active in CKD, we hope to gain a better understanding of the immune responses underlying CKD progression.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
536952
Name
Al-Aubodah Tho-Alfakar
Country
United Kingdom
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Examining the role of renal tertiary lymphoid structures in chronic kidney disease
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Antibodies; B Cells; Chronic Kidney Disease; Confocal Microscopy; Human Immunology; Immunoreceptor Sequencing; Spatial Transcriptomics; T Cells; Tertiary Lymphoid Structures; Tissue Immunology
Abstract
Chronic kidney disease (CKD) is a leading cause of mortality worldwide and the number of cases is climbing annually. Diagnosis is often delayed, leading many individuals to progress to kidney failure needing lifelong dialysis or a kidney transplant to survive. So, in addition to its significant impact on human health, CKD also represents a major economic burden. Injury to the kidney's filtering units is the main risk factor for developing CKD. This is usually instigated by high blood pressure that injures the delicate vasculature of the kidney's filters, or by immune-mediated damage caused by autoimmune diseases and infections. Regardless of the source of injury, subsequent immune responses mediate a chronically inflamed state that interrupts normal kidney repair, triggering the steady march towards kidney failure. We currently have a poor understanding of the immune responses underlying CKD. Consequently, treatments for CKD remain non-specific and offer suboptimal disease control. Hence, by better characterizing the immune processes involved in CKD progression, we can uncover new therapeutic targets to develop better medicine. In this proposal, we aim to uncover these immune processes by applying cutting-edge spatial transcriptomics technologies on kidneys from CKD donors. Specifically, we will examine special immune cell structures - termed tertiary lymphoid structures (TLS) - that develop in the kidney during CKD. Similar TLS develop in the lungs and gut during infection where they act as hubs to promote immunity, and in tumors serving to enhance anti-tumor immune responses. We predict that kidney TLS also act as centres for augmenting immune responses, but ultimately to the detriment of kidney function, thereby promoting CKD progression. By characterizing the cellular composition of these TLS and evaluating the immune pathways that are active in CKD, we hope to gain a better understanding of the immune responses underlying CKD progression.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Al-Aubodah, Tho-Alfakar
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~